Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Colorectal cancer.
Nicum S, Midgley R, Kerr DJ. Nicum S, et al. Acta Oncol. 2003;42(4):263-75. doi: 10.1080/02841860310000412. Acta Oncol. 2003. PMID: 12899497 Review.
Chemotherapy for colorectal cancer.
Nicum S, Midgley R, Kerr DJ. Nicum S, et al. J R Soc Med. 2000 Aug;93(8):416-9. doi: 10.1177/014107680009300807. J R Soc Med. 2000. PMID: 10983503 Free PMC article. Review. No abstract available.
DNA-repair pathway inhibitors for the treatment of ovarian cancer.
Martinek I, Haldar K, Gaitskell K, Bryant A, Nicum S, Kehoe S, Morrison J. Martinek I, et al. Among authors: nicum s. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007929. doi: 10.1002/14651858.CD007929.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2015 May 20;(5):CD007929. doi: 10.1002/14651858.CD007929.pub3 PMID: 20556786 Free PMC article. Updated. Review.
A phase II randomised, placebo-controlled trial of low dose (metronomic) cyclophosphamide and nintedanib (BIBF1120) in advanced ovarian, fallopian tube or primary peritoneal cancer.
Hall MR, Dehbi HM, Banerjee S, Lord R, Clamp A, Ledermann JA, Nicum S, Lilleywhite R, Bowen R, Michael A, Feeney A, Glasspool R, Hackshaw A, Rustin G. Hall MR, et al. Among authors: nicum s. Gynecol Oncol. 2020 Dec;159(3):692-698. doi: 10.1016/j.ygyno.2020.09.048. Epub 2020 Oct 16. Gynecol Oncol. 2020. PMID: 33077258 Clinical Trial.
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
Elyashiv O, Ledermann J, Parmar G, Farrelly L, Counsell N, Feeney A, El-Khouly F, Macdonald I, Neto A, Arthur-Darkwa E, Burnett E, Jayson GC, Mileshkin L, Gourley C, Nicum S. Elyashiv O, et al. Among authors: nicum s. Int J Gynecol Cancer. 2021 Jan;31(1):134-138. doi: 10.1136/ijgc-2020-002073. Epub 2020 Oct 23. Int J Gynecol Cancer. 2021. PMID: 33097567
53 results